185 related articles for article (PubMed ID: 32998675)
1. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
4. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
Zhou Y; Guo Y; Wang Y
IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
8. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
9. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
10. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
12. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Zhang Q; Feng Z; Zhang Y; Shi S; Zhang Y; Ren S
Biomed Res Int; 2021; 2021():6057948. PubMed ID: 34124251
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a five-immune gene prognostic risk model in colon cancer.
Chen H; Luo J; Guo J
BMC Cancer; 2020 May; 20(1):395. PubMed ID: 32375704
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y
Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
17. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.
Wang Y; Lin K; Xu T; Wang L; Fu L; Zhang G; Ai J; Jiao Y; Zhu R; Han X; Cai H
Aging (Albany NY); 2021 Jul; 13(14):19028-19047. PubMed ID: 34315829
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
[TBL] [Abstract][Full Text] [Related]
20. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
Mo S; Pei Z; Dai L
Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
